Form SCHEDULE 13G/A Cineverse Corp. Filed by: CORSAIR CAPITAL MANAGEMENT, L.P.
http://archive.fast-edgar.com/20260814/AB2Z6Q2CH222LZZ2222Q2ZYAL8GVZ2222Z82
Filed on: August 14, 2026
Form 6-K Xinyuan Real Estate Co., For: Aug 14
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
FOR THE MONTH OF August 2026
COMMISSION FILE NUMBER: 001-33863
XINYUAN REAL ESTATE CO., LTD.
27/F, China Central Place, Tower II 79 Jianguo Road, Chaoyang District Beijing 100025 People’s Republic of China
(Address of principal executive... (continue reading...)
Form 13F-NT GOLDMAN SACHS ASSET MANA For: Jun 30
.FormData {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
}
.FormDataC {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
text-align: center;
}
.FormDataR {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
text-align:... (continue reading...)
Form SCHEDULE 13G/A Beacon Financial Corp Filed by: FULLER & THALER ASSET MANAGEMENT, INC.
http://archive.fast-edgar.com/20260814/AQ2ZP22CZ222TT42222N2ZE26VUGZ922BU82
Filed on: August 14, 2026
Form 8-K EIDP, Inc. For: Aug 14 Filed by: Corteva, Inc.
false0001755672DEDE 0001755672 2026-08-14 2026-08-14 0001755672 ctva:EIDPIncMember 2026-08-14 2026-08-14 0001755672 ctva:EIDPIncMember us-gaap:SeriesAPreferredStockMember 2026-08-14 2026-08-14 0001755672 ctva:EIDPIncMember us-gaap:SeriesBPreferredStockMember 2026-08-14 2026-08-14 0001755672 us-gaap:CommonStockMember 2026-08-14 2026-08-14 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to... (continue reading...)
More SEC Filings
View Older Stories-
Form 6-K Elong Power Holding Ltd. For: Aug 14
-
Form 13F-HR III Capital Management For: Jun 30
-
Form PRE 14A BIO KEY INTERNATIONAL For: Sep 03
-
Form 424B3 CITIUS ONCOLOGY, INC.
-
Form S-4 COLONY BANKCORP INC
-
Form 13F-HR ARCH Venture Management, For: Jun 30
-
Form NT 10-Q Charlie's Holdings, Inc. For: Jun 30
-
Form NT 10-Q Jaguar Health, Inc. For: Jun 30
-
Form 40-APP/A Stellus Capital Investme
-
Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: PERCEPTIVE ADVISORS LLC
-
Form N-PX Vantage Point Financial For: Jun 30
-
Form 4 GSI TECHNOLOGY INC For: Aug 13 Filed by: Shu Lee-Lean
-
Form SCHEDULE 13D/A Solid Biosciences Inc. Filed by: PERCEPTIVE ADVISORS LLC
-
Form 4 CTT PHARMACEUTICAL HOLDI For: Aug 12 Filed by: CTT PHARMACEUTICAL HOLDINGS, INC.
-
Form 144 OFG BANCORP Filed by: Arizmendi Maritza
-
Form SCHEDULE 13G/A SUTRO BIOPHARMA, INC. Filed by: PERCEPTIVE ADVISORS LLC
-
Form SCHEDULE 13G/A Spyre Therapeutics, Inc. Filed by: PERCEPTIVE ADVISORS LLC
-
Form SCHEDULE 13G/A X4 Pharmaceuticals, Inc Filed by: PERCEPTIVE ADVISORS LLC
-
Form 10-Q Investcorp Credit Manage For: Jun 30
-
Form 4 RYAN SPECIALTY HOLDINGS, For: Aug 13 Filed by: Conklin Michael
-
Form NT 10-Q AZIO AI HOLDINGS, INC. For: Jun 30
-
Form 10-Q LGL GROUP INC For: Jun 30
-
Form 8-K authID Inc. For: Aug 14
-
Form 8-K QUANTUM CORP /DE/ For: Aug 11
-
Form NT 10-Q Greenwave Technology For: Jun 30
-
Form 13F-HR Bakala Capital LLC For: Jun 30
-
Form 8-K Plum Acquisition Corp. For: Jun 03
-
Form 6-K Greenfire Resources Ltd. For: Aug 14
-
Form 1-A Deedflow INC
-
Form NT 10-Q ULIXE CORP. For: Jun 30
-
Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: PERCEPTIVE ADVISORS LLC
-
Form N-PX CARY STREET PARTNERS For: Jun 30
-
Form SCHEDULE 13G/A enVVeno Medical Corp Filed by: PERCEPTIVE ADVISORS LLC
-
Form N-PX CARY STREET PARTNERS For: Jun 30
-
Form N-PX IRIDIAN ASSET MANAGEMENT For: Jun 30
-
Form 10-Q Franklin Templeton Digit For: Jun 30
-
Form 10-Q DATA I/O CORP For: Jun 30
-
Form S-1/A BIOVIE INC.
-
Form SCHEDULE 13G/A Opus Genetics, Inc. Filed by: PERCEPTIVE ADVISORS LLC
-
Form 10-Q AIAI Holdings Corp For: Jun 30
-
Form 13F-NT Goldman Sachs Bank Europ For: Jun 30
-
Form SCHEDULE 13G/A Invivyd, Inc. Filed by: PERCEPTIVE ADVISORS LLC
-
Form NT 10-Q SeeQC, Inc. For: Jun 30
-
Form SCHEDULE 13D/A Nautilus Biotechnology, Filed by: PERCEPTIVE ADVISORS LLC
-
Form 3 Bausch & Lomb Corp For: Aug 05 Filed by: Chersi Robert J
-
Form SCHEDULE 13G/A Inhibikase Therapeutics, Filed by: PERCEPTIVE ADVISORS LLC
-
Form SCHEDULE 13G/A Inhibrx Biosciences, Filed by: PERCEPTIVE ADVISORS LLC
-
Form 13F-NT EFG Private Bank Ltd For: Jun 30
-
Form 10-Q Security Midwest Bancorp For: Jun 30
-
Form 13F-NT Goldman Sachs Trust Comp For: Jun 30
